Sanofi | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Sunday
November 09, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SUNDAY, NOVEMBER 09, 2025

Sanofi

Sanofi

Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Novavax logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

Novavax signs Covid-19 license deal with Sanofi, removes doubt about business viability

Novavax said it would co-commercialise its Covid-19 vaccine with French drugmaker Sanofi and develop new Covid-19-influenza combination vaccines using Novavax's Matrix-M adjuvant.

The logo of Sanofi is seen at the company's headquarters in Paris, France, April 24, 2020/ Reuters

Healthcare companies Sanofi and GSK to seek Covid-19 vaccine regulatory approval

Beximco Pharma MD Nazmul Hassan, BCIC Chairman Shah Md Imdadul Haque among others at Beximco’s Sanofi acquisition ceremony on Thursday. Photo: Courtesy

Beximco Pharma completes Sanofi acquisition

The logo of Sanofi is seen at the company's headquarters in Paris, France, April 24, 2020. Photo: Reuters

France's Sanofi halts work on mRNA Covid vaccine

Beximco Pharmaceuticals Acquires Sanofi Bangladesh

Beximco Pharma inks Sanofi acquisition deal

Sanofi's Covid-19 vaccine setback, drug pipeline cast long shadow

Sanofi's Covid-19 vaccine setback, drug pipeline cast long shadow

The logo of Sanofi is seen at the company's headquarters in Paris, France, April 24, 2020. Photo: Reuters

Sanofi makes $3.2 bln offer for US mRNA partner Translate Bio

Sanofi to invest in mRNA vaccines development

Sanofi to invest in mRNA vaccines development

Sanofi to start human trials of its second Covid vaccine candidate

Sanofi to start human trials of its second Covid vaccine candidate

Photo: Collected

GSK, Sanofi begin new Covid-19 vaccine trial of protein-based vaccine

A researcher works in an industrial development laboratory at the vaccine unit of French drugmaker Sanofi's Pasteur plant in Marcy-l'Etoile, near Lyon, France June 16, 2020. REUTERS/Gonzalo Fuentes/File Photo

Sanofi's mRNA Covid-19 vaccine candidate not ready this year, CEO says

Photo: BSS/AFP

France's Sanofi to boost Pfizer vaccine supply amid EU shortages

Sanofi Bangladesh Limited Workers-Employees Association gets new committee

Sanofi Bangladesh Limited Workers-Employees Association gets new committee

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net